You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AP-CML

Showing 1 - 25 of 858
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

Terminated
Has Results
  • Chronic Myeloid Leukemia
  • Omacetaxine mepesuccinate
  • Jacksonville, Florida
  • +9 more
Nov 6, 2021

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia Trial in Worldwide (Ponatinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Ph+ Acute Lymphoblastic Leukemia
  • St Leonards, New South Wales, Australia
  • +41 more
Jan 18, 2021

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

Completed
Has Results
  • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
  • Loma Linda, California
  • +35 more
Mar 25, 2021

Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Birmingham, Alabama
  • +25 more
Mar 4, 2022

Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

Recruiting
  • Chronic Myeloid Leukemia in Myeloid Blast Crisis
  • +3 more
  • based decitabine and olverembatinib（HQP1351)chemotherapy
  • Guanzhou, China
    Department of Hematology, Nanfang Hospital, Southern Medical Uni
Dec 6, 2022

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Chronic Myeloid Leukemia (CML) Trial in Italy (Ponatinib 15mg QD, Ponatinib 30mg QD)

Not yet recruiting
  • Chronic Myeloid Leukemia (CML)
  • Ponatinib 15mg QD
  • Ponatinib 30mg QD
  • Cagliari, Italy
  • +12 more
Jan 31, 2021

CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)

Active, not recruiting
  • Chronic Myeloid Leukemia
    • Saint-Pierre, Reunion, France
    • +39 more
    Dec 13, 2021

    Healthy (For Part A), Chronic Myeloid Leukemia (for Part B and C) Trial in Worldwide (Vodobatinib (K0706) capsules)

    Recruiting
    • Healthy (For Part A)
    • Chronic Myeloid Leukemia (for Part B and C)
    • Vodobatinib (K0706) capsules
    • Downey, California
    • +69 more
    Dec 7, 2022

    Chronic Myeloid Leukemia Trial in Germany (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Mannheim, Baden-Wuerttemberg, Germany
    • +69 more
    Mar 21, 2022

    3L+ Therapies Among Chronic Myeloid Leukemia and Those With

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis Investigative Site
      Nov 11, 2022

      Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Trial (Asciminib, Nilotinib)

      Not yet recruiting
      • Philadelphia Chromosome-Positive Chronic Myeloid Leukemia
      • (no location specified)
      Jul 11, 2022

      Trial (Olverembatinib)

      Available
        • (no location specified)
        Nov 10, 2022

        3rd Line Therapy or More to Treat Adult CML- CP in Real World

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Asciminib
        • (no location specified)
        Oct 16, 2023

        Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

        Completed
        Has Results
        • Chronic Myelogenous Leukemia
        • +3 more
        • Duarte, California
        • +100 more
        Jun 8, 2021

        Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Treatment-free Remission
        • TFR(Treatment-Free Remission)
        • (no location specified)
        Jun 27, 2022

        Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

        Recruiting
        • Chronic Myelogenous Leukemia - Chronic Phase
        • Birmingham, Alabama
        • +25 more
        Jan 10, 2023

        Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)

        Recruiting
        • Chronic Myelogenous Leukemia
        • ABL001 40mg BID
        • +2 more
        • Caba, Buenos Aires, Argentina
        • +53 more
        Jan 27, 2023

        CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

        Completed
        • Chronic Phase Chronic Myelogenous Leukemia
        • +3 more
          • Limerick, Dooradoyle, Ireland
          • +32 more
          Aug 13, 2021

          Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

          Recruiting
          • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
          • Longmont, Colorado
          • +128 more
          Aug 1, 2022

          Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

          Completed
          • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
          • Angers, France
          • +9 more
          Aug 17, 2022

          CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

          Not yet recruiting
          • CML, Chronic Phase
          • Harbin, Heilongjiang, China
            Institute of Hematology and Oncology, Harbin The First Hospital
          May 5, 2022

          Leukemia Trial in Houston (Ponatinib)

          Terminated
          Has Results
          • Leukemia
          • Houston, Texas
            University of Texas MD Anderson Cancer Center
          Sep 16, 2019